4.1.4.2.3.3. summary evidence additional recommendations use anticholinergic beta-3 agonists elderly patients. summary evidenceleanticholinergic drugs effective elderly women suffering oab/uui.1bmirabegron shown efficacious safe elderly women suffering oab.1bin older women cognitive impact drugs anticholinergic effects cumulative increases length exposure.2oxybutynin may worsen cognitive function elderly women.2darifenacin, fesoterodine, solifenacin trospium shown cause cognitive dysfunction elderly women short-term studies.1b recommendationsstrength ratinglong-term anticholinergic treatment used caution elderly women, especially risk of, pre-existing cognitive dysfunction.strongassess anticholinergic burden associated co-morbidity women considered anticholinergic therapy overactive bladder syndrome.weak